Phylo
AI agents for biomedical research and genomic data workflows
Updated April 2026
Overview
- Website
- phylo.bio
- Founded
- 2026
- Headquarters
- South San Francisco, CA
- Segment
- Vertical AI
- Posture
- Healthcare
Product overview
Phylo is an applied AI research lab and Stanford spin-out developing agentic AI to accelerate biomedical discoveries. Its flagship product, Biomni Lab, is an Integrated Biology Environment (IBE) that unifies workflows for experiment design, data analysis, literature search, and more in a single platform. The tool integrates hundreds of biological databases and tools, automates data handling, and ensures scientific rigor with hallucination checks and reproducible code.
Revenue model
Freemium model: free cloud service with usage limits; paid edition with enhanced features like custom agents and cybersecurity.
Moat
Phylos Bioscience's key competitive moat is its proprietary elite F1 hybrid cannabis and hemp seeds, developed through a modern scientific breeding program and an 80,000 ft² state-of-the-art R&D facility, which deliver superior flower quality, potency, vigor, yield, and stress tolerance that compete with traditional clonal cultivars while enabling cost-effective, scalable seed-based production for growers. This is reinforced by exclusive genetics like Natural THCV strains, rigorous quality control infrastructure, global innovation partnerships, and variety licensing agreements that create high barriers to entry via specialized germplasm, technical expertise, and market-ready product optimization.
Headwinds
Highly specialized vertical market with complex regulatory requirements and long sales cycles in biomedical research.